Drug intelligence / Profile preview

fluprednisolone

Development stage
Unknown
Lead developer
Pfizer
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Fluprednisolone is a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties. It is structurally related to prednisolone but contains a fluorine atom at the 6-alpha position, which enhances its glucocorticoid activity. Fluprednisolone is approximately 2.5 times as potent as prednisolone and about 40 times as potent as cortisone in terms of anti-inflammatory effect. It is used primarily for the treatment of inflammatory and allergic conditions, as well as other diseases that respond to glucocorticoids, including certain skin diseases. The drug acts by binding to the cytoplasmic glucocorticoid receptor, modulating gene expression to suppress pro-inflammatory cytokines and mediators[1][2][3][4][5][6].

Brand names
Alphadrol
Other names
Fluprednisolonum
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on fluprednisolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluprednisolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call